{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-018011","form_type":"8-K","ticker":"LMAT","cik":"0001158895","company_name":"LEMAITRE VASCULAR INC","filed_at":"2022-07-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.097744+00:00","generated_at":"2026-06-24T07:18:13.504739+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"LeMaitre Vascular Q2 sales $42.1M (+8% organic); raises FY guidance to 10% organic growth","bullets":["Q2 2022 sales $42.1M (+4%, +8% organic); reported EPS $0.16 (-60%); adjusted EPS ex-special charge $0.29 (-26%).","Operating income $5.8M (-48%); ex-$3.1M special charge from closing St. Etienne factory, op income $8.9M (-20%).","FY 2022 guidance raised: sales $162.7M-$165.3M (mid $164M, +10% organic); op income ex-special $32.7M-$34.4M.","Board declared $0.125 quarterly dividend, payable Sept 8 to holders of record Aug 25; $20M share repurchase program ongoing.","Operational milestones: Seoul office opened, French factory closed, Chinese XenoSure cardiac approval filed, Omniflow II CE Mark received."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-018011","json":"https://secwatch.observer/filing/0001437749-22-018011.json","markdown":"https://secwatch.observer/filing/0001437749-22-018011.md","text":"https://secwatch.observer/filing/0001437749-22-018011.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1158895/000143774922018011/0001437749-22-018011-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1158895/000143774922018011/lmat20220728_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T07:18:13.504739+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}